SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD)

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark SHAPING THE FUTURE OF SINGLE VENTRICLE HEART DISEASE (SVHD) was filed as Word mark on 02/14/2020 at the World Intellectual Property Organization.

Trademark Details Last update: July 28, 2022

Trademark form Word mark
File reference 1524898
Countries Australia Switzerland China United Kingdom Israel Japan Mexico Norway New Zealand Russia Singapore
Base trademark US No. 88186670, November 8, 2018
Application date February 14, 2020
Expiration date February 14, 2030

Trademark owner

C & H Building, 3rd Floor,
35 Teheran-ro 87-Gil,
KR

Trademark representatives

550 West Adams Street Chicago IL 60661 US

goods and services

41 Educational services, namely, seminars in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues and distribution of course materials in connection therewith (in the opinion of the International Bureau, the specified terms are too vague for the purposes of classification - Rule 13 (2) (b) of the Common Regulations); providing a website featuring blogs and information in the field of pharmaceuticals, medicine, health, wellbeing, and cardiac issues (in the opinion of the International Bureau, the specified terms are too vague for the purposes of classification - Rule 13 (2) (b) of the Common Regulations)
44 Providing websites featuring information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicine, health, wellness, and cardiac health issues (in the opinion of the International Bureau, the specified terms are too vague for the purposes of classification - Rule 13 (2) (b) of the Common Regulations); medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders; medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation

Trademark history

Date Document number Area Entry
May 19, 2022 2022/24 Gaz MX Rejection
January 12, 2022 2022/7 Gaz AU Rejection
September 16, 2021 2021/37 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 23, 2021 2021/37 Gaz US RAW: Partial Ceasing Effect
August 6, 2021 2021/32 Gaz CH Rejection
June 15, 2021 2021/27 Gaz SG Rejection
May 27, 2021 2021/21 Gaz JP Rejection
May 26, 2021 2021/21 Gaz NO Rejection
May 4, 2021 2021/20 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 19, 2021 2021/12 Gaz NZ RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 26, 2021 2021/10 Gaz CH Rejection
February 8, 2021 2021/6 Gaz RU Rejection
December 5, 2020 2020/51 Gaz NO Rejection
November 10, 2020 2020/46 Gaz GB Rejection
October 7, 2020 2020/42 Gaz NZ Rejection
September 28, 2020 2020/41 Gaz RU Rejection
September 25, 2020 2020/40 Gaz AU Rejection
August 28, 2020 2020/36 Gaz CN Rejection
July 28, 2020 2020/32 Gaz IL Rejection
July 8, 2020 2020/29 Gaz SG Rejection
April 30, 2020 2020/19 Gaz GB Rejection
February 14, 2020 2020/13 Gaz US Registration

ID: 141524898